Preparing for success in modernizing the science behind the development and regulation of medical products
ACDRS 2021 Session 6: Integrated Product Development, Project Management, and Portfolio Management; Preparing for Transition to Market
Date:
Monday, December 6, 2021 - 10:00 am to Friday, December 10, 2021 - 3:00 pm
Location:
virtual/online
This is Session 6 of 6. Must register for the entire course and not per Session.
Session Chairperson: Charlie T. Gombar, PhD, ACDRS Director
Topics
- Portfolio management: principles, challenges, and strategies
- Role of licensing in portfolio management
- Project management: principles, challenges, and strategies
- Judgment under uncertainty
- Integrated global strategy
- Turning strategy into plans
- Co-development and alliances
- Strategic marketing (commercial) role in development
- How to launch a new drug successfully into the market
- Digital transformation and artificial intelligence
- Prescription drug promotion
- Promotional committee review simulation
- Pharmacovigilance
- Leadership strategies in drug development and regulation
Lecturers
Sue Duvall, RN, MPA |
Consultant |
Charlie T. Gombar, PhD |
ACDRS Director |
Richard Heaslip, PhD |
President and Founder, Programmatic Sciences LLC |
Craig H. Mallinckrodt, PhD |
Senior Director, Research and Early Development Statistics, Biogen |
Mark Noguchi, MBA | Senior Vice President and Head, Chugai Partnering, Chugai Pharmaceuticals (Japan) |
Christiane Pering, MD | Head of Medical Devices & eHealth, Bayer Pharmaceuticals (Germany) |
Jennifer C. Power, MBA | BioPharma Commercial Executive |